
Easyfour-TT 0.5ml Vaccine
Salt Composition: Diphtheria(30IU), Haemophilus influenzae type b, Hepatitis-B, Pertussis(4IU), and Tetanus(60IU), Conjugate Vaccine(10MCG)
Expiry Date: 01/2028
Inclusive of all taxes
1 Vial in a Pack

Easyfour-TT 0.5ml Vaccine
1 Vial in a Pack
Diphtheria(30IU), Haemophilus influenzae type b, Hepatitis-B, Pertussis(4IU), and Tetanus(60IU), Conjugate Vaccine(10MCG)
Salt Composition
Diphtheria(30IU), Haemophilus influenzae type b, Hepatitis-B, Pertussis(4IU), and Tetanus(60IU), Conjugate Vaccine(10MCG)
Storage
2–8°C
Expiry Date
01/2028
Marketer
panacea biotec
Brand
Easyfour-TT
5966.png&w=1920&q=75)
MAGIC DEALS
Buy at $21.88
Apply Promo Code
Available CouponsEasyfour-TT 0.5ml Vaccine
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate
Overview
Easyfour-TT 0.5ml Vaccine that protects against four diseases namely tetanus, diphtheria, pertussis (whooping cough), and haemophilus influenzae type b. It contains the toxoid against these diease to trigger the immune response.
This vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age. It is an adsorbed liquid formulation that is ready to use.
Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems. Also, let the medical healthcare team know if your child is allergic to any medicine.
Easyfour-TT 0.5ml Vaccine Uses and Indications
Prevention of Tetanus
Prevention of Pertussis
Prevention of Diphtheria
Prevention of Haemophilus influenzae Type b disease
Easyfour-TT 0.5ml Vaccine Side Effects
Undesired symptoms or responses vary from individual to individual as the human body reacts differently to the Easyfour-TT 0.5ml Vaccine , but they disappear naturally within a few days as the body adjusts to the vaccine, which requires no medical attention. In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
Some of the common side effects of the vaccine are:
Irritability
Vomiting
Fever
Diarrhea
Local site pain
Restlessness
Drowsiness
Easyfour-TT 0.5ml Vaccine Dosage and How To Take It
The Easyfour-TT 0.5ml Vaccine is given into the deltoid muscle of the upper arm. It is an intramuscular Vaccine. Do not use the same Vaccine or syringe for another vaccine, as there is a chance of interaction.
This vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age. It is an adsorbed liquid formulation that is ready to use. Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems.
Also, let the medical healthcare team know if your child is allergic to any medicine.
How Easyfour-TT 0.5ml Vaccine Works
Easyfour-TT 0.5ml is a vaccine that contains the toxoid of diphtheria, tetanus, pertussis, and Haemophilus Influenzae type b. When this vaccine is given to an individual then it stimulates the immune system to produce specific antibodies against the toxins, but doesn’t cause disease.
These antibodies and memory cells formed after taking the Vaccine identify and counteract the toxins and generate memory for it, and neutralize it with a stronger immune response upon subsequent exposure within a few hours. This provides immunity within 2 to 4 weeks and for many years.
Safety Advice for Easyfour-TT 0.5ml Vaccine
Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Easyfour-TT 0.5ml Vaccine, as per the research.
The Easyfour-TT 0.5ml Vaccine should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. This vaccine is generally not safe to take during pregnancy as it is meant for children and infants. Pregnant women should receive Tdap vaccines to protect the developing baby from pertussis.
Driving after taking the Easyfour-TT 0.5ml Vaccine does not affect or interfere with driving ability or disturb while operating machinery. There are no records found that show it affects the coordination or mental alertness. However, if you get a fever or dizziness after the Vaccine, avoid driving until you feel better
The Easyfour-TT 0.5ml Vaccine is generally considered beneficial and safe for people with chronic liver disease, and vaccination is strongly recommended for people who are at high risk of getting severe tetanus, Diphtheria, and Pertussis.
FAQs About Easyfour-TT 0.5ml Vaccine
Easyfour-TT 0.5ml Vaccine is given to infants in 3 doses starting from 1st dose given after 6 weeks, 2nd dose after 10 weeks and 3rd week after 14 weeks.
References
Gandhi, D. J., Dhaded, S. M., Ravi, M. D., Dubey, A. P., Kundu, R., Lalwani, S. K., ... & Dhingra, M. S. (2016). Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants. Human Vaccines & Immunotherapeutics , 12 (4), 946-954.
Dhingra, M. S., Rao, R., Bhat, S., Joshi, R., Kalra, V., Parikh, H. R., ... & Muzaffaruddin, M. (2010). Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: A phase III trial. Human vaccines , 6 (7), 572-577.
Sharma, H. J., Patil, V. D., Lalwani, S. K., Manglani, M. V., Ravichandran, L., Kapre, S. V., ... & Shewale, S. D. (2012). Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process. Vaccine , 30 (3), 510-516.
Thang, H. V. (2015). Immunogenicity and safety of Quinvaxem®(diphtheria, tetanus, whole-cell pertussis, hepatitis B and haemophilus influenzae Type B vaccine) given to vietnamese infants at 2 to 4 months of age. The Southeast Asian journal of tropical medicine and public health .
Li, Y., Li, R. C., Ye, Q., Li, C., Liu, Y. P., Ma, X., ... & Mesaros, N. (2017). Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants. Human vaccines & immunotherapeutics , 13 (3), 588-598.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)